Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Capital/Financing Update 2014

Nov 20, 2014

35121_rns_2014-11-20_46248a00-a91e-4110-ad45-40b189bc421f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New Issue Announcement, Application for Quotation of Additional Securities and Agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of Entity

Immuron Limited (ASX: IMC)

ABN

80 063 114 045

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be issued
2
Number of+securities issued or to be issued (if
known) or maximum number which may be issued
3
Principal terms of the+securities (e.g. if options,
exercise price and expiry date; if partly paid
+securities, the amount outstanding and due dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for conversion)
4
Do the+securities rank equally in all respects from
the+issue date with an existing+class of quoted
+securities?
If the additional+securities do not rank equally,
please state:
• the date from which they do
• the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
• the extent to which they do not rank equally,
other than in relation to the next dividend,
distribution or interest payment
Ordinary Shares (IMC)
72,916
Fully Paid Ordinary Shares (IMC)
Yes (IMC)
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 1

5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the acquisition of
assets, clearly identify those assets)
6a
Is the entity an+eligible entity that has obtained
security holder approval under rule 7.1A?
If Yes, complete sections 6b – 6hin relation to the
+securities the subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder resolution under rule
7.1A was passed
6c
Number of+securities issued without security holder
approval under rule 7.1
6d
Number of+securities issued with security holder
approval under rule 7.1A
6e
Number of+securities issued with security holder
approval under rule 7.3, or another specific security
holder approval (specify date of meeting)
6f
Number of+securities issued under an exception in
rule 7.2
6g
If+securities issued under rule 7.1A, was issue price
at least 75% of 15 day VWAP as calculated under rule
7.1A.3? Include the+issue date and both values.
Include the source of the VWAP calculation.
6h
If+securities were issued under rule 7.1A for non-
cash consideration, state date on which valuation of
consideration
was
released
to
ASX
Market
Announcements
6i
Calculate the entity’s remaining issue capacity under
rule 7.1 and rule 7.1A – complete Annexure 1 and
release to ASX Market Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX (refer to the definition of
issue date in rule 19.12). For example, the issue date for a pro rata
entitlement issue must comply with the applicable timetable in Appendix
7A.
Cross reference: item 33 of Appendix 3B.
Nil Consideration
As
per
Resolution
3
approved
by
shareholders at the Annual General Meeting
of the Company held on Thursday, 13th
November 2014.
Yes
Thursday, 13thNovember 2014
Nil
Nil
72,916 Ordinary Fully Paid Shares (IMC)
Thursday, 13thNovember 2014
Nil

N/A
N/A
Refer to the attached Appendix 1
Friday, 21stNovember 2014
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 2

8
Number and+class of all+securities
quoted
on
ASX
(including
the
+securities in section 2 if applicable)
Number +Class
74,964,232
2,899,197
Fully Paid Ordinary Shares (IMC)
Listed Options exercisable at $1.556 on
or before 30 April 2015(IMCOA)
  • Consolidated on a 40:1 basis as per resolution 5 approved by shareholders at the Annual General Meeting of the Company held on 13 November 2014

  • 9 Number and[+] class of all[+] securities not quoted on ASX (including the +securities in section 2 if applicable)

Number +Class(Options over OrdinaryShares) +Class(Options over OrdinaryShares) +Class(Options over OrdinaryShares)
Amount Exercise
Price
Expiration
Date
ASX Code
50,000* $1.556 30 June 2015 IMCSO1
3,882,929* $0.376 31 Mar 2016 IMCAI
793,650* $0.276 30 June 2016 IMCAI
1,250,000* $0.456 4 Dec 2016 IMCAI
62,500* $1.556 1 Nov 2017 IMCSO2
14,493* $1.944 30 Nov 2021 IMCRM1
29,668* $1.876 17 Jan 2022 IMCRM2
15,380* $1.892 28 Feb 2019 IMCAI
140,056* $0.300 28 May 2019 IMCAI
6,238,676 Total
  • Consolidated on a 40:1 basis as per resolution 5 approved by shareholders at the Annual General Meeting of the Company held on 13 November 2014

  • 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Unchanged

Part 2 - Pro rata issue

  • 11 Is security holder approval required?

  • 12 Is the issue renounceable or non-renounceable?

  • 13 Ratio in which the[+] securities will be offered

  • 14 +Class of +securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

  • 17 Policy for deciding entitlements in relation to fractions

  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 3

18 Names of countries in which the entity has security Names of countries in which the entity has security
holders who will not be sent new offer documents
Note: Security holders must be told how their entitlements are to be dealt
with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of acceptances or
renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or commission
22 Names of any brokers to the issue
23 Fee or commission payable to the broker to the issue
24 Amount of any handling fee payable to brokers who
lodge acceptances or renunciations on behalf of
security holders
25 If the issue is contingent on security holders’
approval, the date of the meeting
26 Date entitlement and acceptance form and offer
documents will be sent to persons entitled
27 If the entity has issued options, and the terms entitle
option holders to participate on exercise, the date
on which notices will be sent to option holders
28 Date rights trading will begin
(if applicable)
29 Date rights trading will end
(if applicable)
30 How do security holders sell their entitlementsin full
through a broker?
31 How do security holders sellpartof their
entitlements through a broker and accept for the
balance?
32 How
do
security
holders
dispose
of
their
entitlements
(except by sale through a broker)?
33 +Issue date
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 4

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities (tick one)

  • (a) +Securities described in Part 1

  • (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional[+] securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of[+] securities for which[+] quotation is sought

39 +Class of +securities for which quotation is sought 40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 5

  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

  • (if issued upon conversion of another[+] security, clearly identify that other[+] security)

  • 42 Number and[+] class of all[+] securities quoted on ASX (including the[+] securities in clause 38)

Number +Class

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [99 x 39] intentionally omitted <==

Sign here: ______ Company Secretary

Date: Friday, 21[st] November 2014

Print name: Peter Vaughan

==> picture [38 x 23] intentionally omitted <==

The CFO Solution

Friday, 21[st] November 2014

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 6

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Rule 7.1 – Issues exceeding 15% of capital Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid+ordinary securities on issue 12
months before the+issue date or date of agreement to
issue
25,886,254
Addthe following:
• Number of fully paid+ordinary securities issued in that
12 month period under an exception in rule 7.2
• Number of fully paid+ordinary securities issued in that
12 month period with shareholder approval
• Number of partly paid+ordinary securities that
became fully paid in that 12 month period
Note:
• Include only ordinary securities here – other classes of
equity securities cannot be added
• Include here (if applicable) the securities the subject of
the Appendix 3B to which this form is annexed
• It may be useful to set out issues of securities on
different dates as separate line items
48,293,635 (LR 7.2)
784,343 (LR 7.3)
Subtractthe number of fully paid+ordinary securities
cancelled during that 12 month period
Nil
“A” 74,964,232
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 11,244,635
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 7

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already
been used
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already
been used
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already
been used
Insertnumber of+equity securities issued or agreed to be
issued in that 12 month periodnot countingthose issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule 7.1 or rule
7.4
Note:

This applies to equity securities, unless specifically excluded – not just
ordinary securities

Include here (if applicable) the securities the subject of the Appendix
3B to which this form is annexed

It may be useful to set out issues of securities on different dates as
separate line items
Nil
“C” Nil

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under
rule 7.1
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under
rule 7.1
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under
rule 7.1
“A” x 0.15
Note: number must be same as shown in Step 2
11,244,635
Subtract“C”
Note: number must be same as shown in Step 3
Nil
Total[“A” x 0.15] – “C” 11,244,635
[Note: this is the remaining placement capacity
under rule 7.1]
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 8

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Rule 7.1A – Additional placement capacity for eligible entities Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A”
Note: number must be same as shown in Step 1 of Part 1
74,964,232

Step 2: Calculate 10% of “A”

Step 2: Calculate 10% of “A” Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply“A” by 0.10 7,496,423

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has
already been used
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has
already been used
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has
already been used
Insertnumber of+equity securities issued or agreed to be
issued in that 12 month period under rule 7.1A
Notes:

This applies to equity securities – not just ordinary securities

Include here – if applicable – the securities the subject of the
Appendix 3B to which this form is annexed

Do not include equity securities issued under rule 7.1 (they must be
dealt with in Part 1), or for which specific security holder approval
has been obtained

It may be useful to set out issues of securities on different dates as
separate line items
Nil
“E” Nil

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under
rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under
rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under
rule 7.1A
“A” x 0.10
Note: number must be same as shown in Step 2
7,496,423
Subtract“E”
Note: number must be same as shown in Step 3
Nil
Total[“A” x 0.10] – “E” 7,496,423
Note:
This is the remaining placement capacity under
rule 7.1A
  • See chapter 19 for defined terms. 04/03/2013

Appendix 3B Page 9

==> picture [208 x 58] intentionally omitted <==

ASX ANNOUNCEMENT

Notice Under Section 708A(5) of the Corporations Act [ASX Code: IMC]

Friday, 21[st] November 2014

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

Type: Shares
Class/Description: Ordinary Fully Paid
ASX Code: IMC
Date of Issue: Friday, 21stNovember 2014
Number Issued: 72,916
Issue Price: Nil Consideration

The Company intends to apply to Australian Stock Exchange Limited for quotation of the above shares.

Accordingly the Company gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:

  1. the abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

  2. as at the date of this notice the Company has complied with:

  3. (i) the provisions of Chapter 2M Corporations Act as they apply to the Company; and

  4. (ii) section 674 Corporations Act; and

  5. as at the date of this notice there is no "excluded information" (as defined in subsection 708A(7) of the Corporations Act) which is required to be disclosed by the Company.

For and on behalf of the Company,

==> picture [117 x 44] intentionally omitted <==

Peter Vaughan Company Secretary